Desh Rakshak Aushdhalaya Limited (BOM:531521)
32.00
0.00 (0.00%)
At close: Jan 16, 2026
Desh Rakshak Aushdhalaya Revenue
Desh Rakshak Aushdhalaya had revenue of 9.54M INR in the quarter ending September 30, 2025, a decrease of -19.75%. This brings the company's revenue in the last twelve months to 62.53M, down -1.31% year-over-year. In the fiscal year ending March 31, 2025, Desh Rakshak Aushdhalaya had annual revenue of 62.71M with 4.37% growth.
Revenue (ttm)
62.53M
Revenue Growth
-1.31%
P/S Ratio
2.92
Revenue / Employee
3.13M
Employees
20
Market Cap
182.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 62.71M | 2.63M | 4.37% |
| Mar 31, 2024 | 60.08M | -1.72M | -2.79% |
| Mar 31, 2023 | 61.80M | -91.20K | -0.15% |
| Mar 31, 2022 | 61.89M | -4.09M | -6.19% |
| Mar 31, 2021 | 65.98M | 15.11M | 29.72% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.46B |
| Sunrest Lifescience | 520.34M |
| Medicamen Organics | 394.30M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 191.97M |
| Zenith Healthcare | 112.08M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |